Marton, Laurence, MD

Program Chair, PMWC


Dr. Marton serves as a consultant to industry and to governmental, not-for-profit, and academic institutions. He is an Adjunct Professor in the Department of Laboratory Medicine at the University of California, San Francisco (UCSF). In recent years, Dr. Marton has served as CSO of Progen Pharmaceuticals and of Cellgate, and as a founder, director, CSO, CMO, and CEO of the SLIL Biomedical Corp. These companies focused on the discovery and development of novel polyamine analogs and other compounds for the treatment of cancer and other serious diseases. Before moving from academia to industry, Dr. Marton was Dean of the University of Wisconsin-Madison Medical School and previously Chaired the Department of Laboratory Medicine at UCSF, where he was a Professor in the Departments of Laboratory Medicine and Neurological Surgery and a Senior Investigator in the Brain Tumor Research Center. He is a leading expert with extensive experience in the fields of cell growth and drug development. His research has resulted in more than 185 original publications, 60 scientific reviews and chapters, four books, numerous patents, and his work has been acknowledged internationally. Dr. Marton serves on the Board of the California Heart Center Foundation, is an advisor to the American Association for Cancer Research, and served on the Wisconsin Technology Council. He is Chairman of the Scientific Advisory Board of PharmaJet, is on the Advisory Board of Ruga Corp, and is a member of the Advisory Board of Silicom Ventures. Dr. Marton received his MD from the Albert Einstein College of Medicine.

Listen to an interview with Larry